Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

darbepoetin alfa

(dar-bee-POH-ee-tin AL-fuh)
A drug used to treat anemia caused by chronic kidney disease and some types of chemotherapy. Darbepoetin alfa is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Darbepoetin alfa is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called Aranesp.
More Information
Search NCI's Dictionary of Cancer Terms